Intravenous immunoglobulin as salvage therapy in refractory pyoderma gangrenosum: Report of a case and review of the literature

Case Reports in Dermatology

Volumn 6, Issue 3, 2014, Pages 239-244

  Cafardi, John ^a   Sami, Naveed ^b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Intravenous immunoglobulin; Pyoderma gangrenosum; Treatment

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOSPORIN; DAPSONE; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID; PREDNISONE;

ADULT; CASE REPORT; FEMALE; HUMAN; HUMAN TISSUE; LEG ULCER; LOW DRUG DOSE; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; REVIEW; SALVAGE THERAPY; SKIN BIOPSY; SKIN ULCER; TREATMENT RESPONSE;

EID: 84929460709     PISSN: None     EISSN: 16626567     Source Type: Journal    
DOI: 10.1159/000368824     Document Type: Review

References (13)

1. Ruocco E, Sangiuliano S, Gravina AG, Miranda A, Nicoletti G: Pyoderma gangrenosum: An updated review. J Eur Acad Dermatol Venereol 2009;23:1008-1017.
2. Gupta AK, Shear NH, Sauder DN: Efficacy of human intravenous immune globulin in pyoderma gangrenosum. J Am Acad Dermatol 1995;32:140-142.
3. Cummins DL, Anhalt GJ, Monahan T, Meyerle JH: Treatment of pyoderma gangrenosum with intravenous immunoglobulin. Br J Dermatol 2007;157:1235-1239.
4. Dirschka T, Kastner U, Behrens S, Altmeyer P: Successful treatment of pyoderma gangrenosum with intravenous human immunoglobulin. J Am Acad Dermatol 1998;39:789-790.
5. de Zwaan SE, Iland HJ, Damian DL: Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin. Australas J Dermatol 2009;50:56-59.
6. Hagman JH, Carrozzo AM, Campione E, Romanelli P, Chimenti S: The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum. J Dermatolog Treat 2001;12:19-22.
7. Meyer N, Ferraro V, Mignard MH, Adamski H, Chevrant-Breton J: Pyoderma gangrenosum treated with high-dose intravenous immunoglobulins: Two cases and review of the literature. Clin Drug Investig 2006;26:541-546.
8. Suchak R, Macedo C, Glover M, Lawlor F: Intravenous immunoglobulin is effective as a sole immunomodulatory agent in pyoderma gangrenosum unr esponsive to systemic corticosteroids. Clin Exp Dermatol 2007;32:205-207.
9. Sinnya S, Hamza S: Pyoderma gangrenosum of the breast treated with intravenous immunoglobulin. J Dermatol Case Rep 2013;7:64-68.
10. Zhang XB, He YQ, Zhou H, Luo Q, Li CX: A case of pyoderma gangrenosum responding to high-dose intravenous immunoglobulin therapy. Chin Med J (Engl) 2006;119:1230-1232.
11. Tamaki K, Nakazawa T, Mamehara A, Tsuji G, Saigo K, Kawano S, Morinobu A, Kumagai S: Successful treatment of pyoderma gangrenosum associated with myelodysplastic syndrome using high-dose intravenous immunoglobulin. Intern Med 2008;47:2077-2081.
12. Erf urt-Berge C, Herbst C, Schuler G, Bauerschmitz J: Successful treatment of pyoderma gangrenosum with intravenous immunoglobulins during pregnancy. J Cutan Med Surg 2012;16:205-207.
13. Kreuter A, Reich-Schupke S, Stucker M, Altmeyer P, Gambichler T: Intravenous immunoglobulin for pyoderma gangrenosum. Br J Dermatol 2008;158:856-857.